Positive opinion from ISA-Israel patent office Provides the ability to file a patent application under the Patent Prosecution Highway (PPH) in the US
- Israeli Technology Company BYND Cannasoft Enterprises Expands Intellectual Property Portfolio for Its EZ-G Device by filing national phase application for Its EZ-G Device in 11 jurisdictions, including U.S. utility patent application under the Patent Prosecution Highway (PPH) and the European Patent Office (EPO), which includes 38 European countries Israeli Technology Company BYND Cannasoft Enterprises Expands Intellectual Property Portfolio for Its EZ-G Device by filing national phase application for Its EZ-G Device in 11 jurisdictions, including U.S. utility patent application under the Patent Prosecution Highway (PPH) and the European Patent Office (EPO), which includes 38 European countries
- 12/18/2023
|
Israel's Finance Ministry Increases Israel Innovation Authority's High-Tech Sector Fast-Track Fund to $100 Million During Wartime
- ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 16, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”), announced today on submitting a research and development plan based on a planned budget of US$1.5 million (grant of up to US$0.75 million) to develop CRM software combined with AI for the medical cannabis industry (File number 82745 – Application number 01125047). Israel's Finance Ministry recently clarified its decision to increase the wartime high-tech sector fund to provide short- and long-term measures designed to assist startup companies in Israel's high-tech sector. The Company was found suitable for submitting the application according to the criteria required in the grant program as detailed on the Israel Innovation Authority website.
- 11/16/2023
|
Israeli Ministry of Health Reports Surge in Medical Cannabis Patients Following Recent Events
- ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”), announced today a new plan of work that focuses on its proprietary CRM platform in an effort to help meet the increased demand for medical cannabis in Israel. Recent regulatory reforms approved by the Israeli Ministry of Healthi allows physicians to prescribe cannabis to patients as a first-line treatment rather than as an option of last resort. Israel has had a significant increase in the number of licensed medical cannabis patientsii in the wake of recent events, particularly the opening of the war in Gaza. This surge has resulted in more than 2,000 new patients in just one month, approaching the peak numbers of 2021 and bringing the total number to over 132,000 as of November 2023. BYND Cannasoft's proprietary Benefit CRM enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, workforce management, contact center operations, and asset management. Benefit CRM is provisioned as SaaS to some of Israel's most recognizable companies.
- 11/07/2023
|
Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Announces Second Quarter 2023 Financial Results
- VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN, CSE: BYND) (“BYND” or the “Company”) has released its financial results for the six-month period ended June 30, 2023. Full versions of BYND's unaudited consolidated interim financial statements and management discussion and analysis for the period can be found on www.sedar.com.
- 08/08/2023
|
BYND Cannasoft CEO Delivers Update Amidst Promising Milestones
- ASHKELON, Israel and VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") today announced that Yftah Ben Yaackov, Chief Executive Officer and Director, shared a comprehensive update on the Company's progress, highlighting significant recent milestones and unveiling promising prospects for the future.
- 08/03/2023
|
Israeli Technology Company BYND Cannasoft Enterprises Files US Provisional Patent Application and Full Scale PCT Application for Its EZ-G Device
- The patent application listed as Publication Number WO/2023/13195 was published on the World Intellectual Property Organization's global database for intellectual property on July 13, 2023 The patent application listed as Publication Number WO/2023/13195 was published on the World Intellectual Property Organization's global database for intellectual property on July 13, 2023
- 07/31/2023
|
BYND Cannasoft Provides EZ-G Device Milestones for the Second Half of 2023
- ASHKELON, Israel and VANCOUVER, British Columbia, July 25, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") today announced several milestones for the second half of 2023 on the development of its groundbreaking EZ-G Device. The EZ-G device, a therapeutic solution utilizing AI and machine learning, could enhance therapeutic approaches for women's health issues by offering cutting-edge technology to cater to the evolving needs of consumers. Moreover, the company is actively negotiating with synergistic businesses, particularly those in the CBD oils sector, for a transformative transaction.
- 07/25/2023
|
Aegis Capital Corp. Acted as Sole Bookrunner on a $2.6 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN)
- NEW YORK, NY / ACCESSWIRE / July 19, 2023 / Aegis Capital Corp. acted as Sole Bookrunner on a $2.6 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN). About BYND Cannasoft Enterprises Inc. BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel.
- 07/19/2023
|
BYND Cannasoft Closes US$2.6 Million Underwritten Public Offering
- ASHKELON, Israel and VANCOUVER, British Columbia, July 19, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) today announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company of approximately US$2.6 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The base offering consisted of 1,733,334 common shares at a price to the public of US$1.50 per share. The Company intends to use the net proceeds from this offering primarily for product design and manufacturing, sales and marketing campaigns, patent prosecution and working capital.
- 07/19/2023
|
BYND Cannasoft Announces Pricing of US$2.6 Million Underwritten Public Offering
- ASHKELON, Israel and VANCOUVER, British Columbia, July 17, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately US$2.6 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The base offering consists of 1,733,334 common shares at a price to the public of US$1.50 per share. The Company intends to use the net proceeds from this offering for working capital.
- 07/17/2023
|
Why Is BYND Cannasoft Enterprise (BCAN) Stock Down 46% Today?
- BYND Cannasoft Enterprise (NASDAQ: BCAN ) stock is dropping on Monday after the company announced an underwritten stock offering. BYND Cannasoft Enterprise announced the underwritten offering after markets closed on Friday.
- 07/17/2023
|
BYND Cannasoft stock drops on announced secondary offering
- Shares of BYND Cannasoft Enterprises Inc. BCAN, -0.45% shares dropped in the extended session Friday after the cannabis business software company said it was issuing a secondary offering. BYND Cannasoft shares fell 19% after hours, following a 0.5% rise to close Friday at $3.12.
- 07/14/2023
|
BYND Cannasoft Announces Successful Completion of Laboratory Testing Phase for EZ-G Device Optimization
- ASHKELON, Israel and VANCOUVER, British Columbia, July 10, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today the successful completion of the laboratory testing phase aimed at optimizing the various sensors in its innovative EZ-G device. The EZ-G device, a therapeutic solution utilizing AI and machine learning, has shown promise in releasing low concentrations of CBD oils, including hemp seed oil and other natural oils, to potentially address specific women's health issues.
- 07/10/2023
|
Why Is BYND Cannasoft (BCAN) Stock Up 10% Today?
- BYND Cannasoft Enterprises (NASDAQ: BCAN ) stock is on the rise Thursday after the company revealed a patent for AI tech in the U.S. The patent has to do with a device for treating certain phenomena in female sexual organs. The company notes that this patent is connected to its plan to break into the multibillion-dollar Sextech Industry.
- 03/09/2023
|